Table I.
Laboratory results of the patient on different days of hospitalization
| Variable | HD1∗ | HD2∗ | HD3 | Extreme values HD4 to HD12 | Reference range |
|---|---|---|---|---|---|
| WBC 109/L |
14.0 | 15.8 | 16.3 | 15.7 | 3.5-10 |
| RBC 1012/L |
5.06 | 4.42 | 4.52 | 2.75 | 3.50-5.50 |
| Platelet (×109/L) | 210 | 248 | 318 | 51 | 150-400 |
| D-dimer (ng/mL) | 0.95 | 4.05 | 2.65 | 6.57 | <0.55 |
| PT (seconds) | 12.8 | 12.5 | 12.2 | 14.9 | 10.3-13.0 |
| LDH (U/L) | 464 | 499 | 538 | 750 | 81-234 |
| Ferritin (μg/L) | 438 | / | / | / | 20-290 |
| CRP (mg/dL) | >201 | 162 | 155 | 280 | 0-10 |
| SpO2 (%) | 70 | 97 | 92 | 88 | 92-100 |
| pH | / | 7.34 | 7.39 | 7.52 | 7.35-7.45 |
| pO2 (mmHg) | / | 34 | 62 | 41 | 90-100 |
| Lactates (mmol/L) | / | 2.9 | 1.3 | 1.6 | 0.5-2.2 |
| Treatment |
AZM 500 mg CFX 2 g MPS 120 mg Fraxiparin 0.6 mL × 2 |
AZM 500 mg CFX 2 g MPS 120 mg Fraxiparin 0.6 mL × 2 NA Lopinavir 200 mg Ritonavir 50 mg CPAP |
AZM 500 mg CFX 2 g MPS 120 mg Fraxiparin 0.6 mL × 2 NA CPAP |
Meropenem 1500 mg CFX 2 g MPS 120 mg Fraxiparin 0.6 mL × 2 NA IMV (IPPV) |
AZM, Azythromicin; CFX, ceftriaxone; CRP, C-reactive protein; CPAP, continuous positive airway pressure therapy; IMV, invasive mechanical ventilation; IPPV, intermittent positive-pressure ventilation; LDH, lactate dehydrogenase; MPS, methylprednisolone; HD hospital day; NA, noradrenaline; PT, prothrombin time; RBC, red blood cells; SpO2, oxygen saturation; WBC, white blood cells.
∗
Bold formatting indicates results when livedo reticularis persisted.